Dynamic changes in orbitofrontal neuronal activity in rats during opiate administration and withdrawal.
The orbitofrontal cortex is involved in the reinforcing effects of drugs of abuse. However, how the dynamic activity in OFC changes during opiate administration and withdrawal period has not been investigated. We first tested the effects of opiates and drug craving with the conditioned place preference paradigm, using manganese-enhanced magnetic resonance imaging and traditional electroencephalograph recording techniques in rats. T1-weighted 2D MRI (4.7 T) was used after unilateral injection of MnCl(2) (200 nL, 80 mM) into the right orbitofrontal cortex. The manganese-enhanced magnetic resonance imaging data suggested that the OFC activity decreased during the opiate administration period but recovered increasingly during the withdrawal period. Also, we found decreases and increases in gamma-band (20-100 Hz) activity during the opiate administration and withdrawal period, respectively. Our results showed that orbitofrontal cortex activity decreased during morphine administration and then went up progressively over several days during withdrawal. The time course of the recovery of orbitofrontal activity from inhibition during the withdrawal period may be related to the experience of drug craving.
Sun
N
N
Laboratory of Primate Cognitive Neuroscience, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming, Yunnan 650223, PR China.
Li
Y
Y
Tian
S
S
Lei
Y
Y
Zheng
J
J
Yang
J
J
Sui
N
N
Xu
L
L
Pei
G
G
Wilson
F A W
FA
Ma
Y
Y
Lei
H
H
Hu
X
X
D000818:Animals; D003216:Conditioning, Operant / Q000187:drug effects; D004569:Electroencephalography; D008279:Magnetic Resonance Imaging; D008297:Male; D008345:Manganese; D009020:Morphine / Q000494:pharmacology*; D009294:Narcotics / Q000494:pharmacology*; D009474:Neurons / Q000187:drug effects*; D017397:Prefrontal Cortex / Q000187:drug effects* / Q000503:physiopathology*; D051381:Rats; D017207:Rats, Sprague-Dawley; D013238:Stereotaxic Techniques; D013375:Substance Withdrawal Syndrome / Q000503:physiopathology*
D009294:Narcotics; D008345:Manganese; D009020:Morphine